Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: A matched pair analysis

被引:0
|
作者
Dahlstrom, KR
Adler-Storthz, K
Etzel, CJ
Liu, ZS
Dillon, L
El-Naggar, AK
Spitz, MR
Schiller, JT
Wei, QY
Sturgis, EM
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, Hlth Sci Ctr, Houston Dent Branch, Houston, TX 77225 USA
[5] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Infection with human papillomavirus (HPV) type 16 has been suggested to be a risk factor for squamous cell carcinoma of the head and neck (SCCHN) and to be more commonly associated with SCCHN occurring in the oropharynx and in never-smokers. We hypothesized that HPV-16 exposure, as evidenced by seropositivity, is a risk factor for SCCHN and may be of particular importance in never-smokers. Experimental Design: To test this hypothesis, we conducted a hospital-based case-control study of 120 patients with SCCHN (60 never-smokers and 60 matched smokers) and 120 cancer-free matched controls. We compared the presence of HPV-16 antibodies in ever-smoker and never-smoker patients matched on age (+/-5 years), sex, and tumor site. Each patient was also matched with a corresponding ever-smoker or never-smoker cancer-free control on age (+/-5 years) and sex. Serum was collected from study subjects and assayed for IgG reactivity to HPV-16 L1 virus-like particles by using an ELISA. Results: Forty-nine of the 120 case subjects (40.8%) but only 11 (9.2%) of the control subjects tested positive for HPV-16 antibodies (adjusted odds ratio, 6.69; 95% confidence interval, 3.01-14.90). Among cases, HPV-16 seropositivity was more common in those with oropharyngeal cancer (41 of 70, 58.6%) and poorly differentiated tumors (25 of 43, 58.1%). HPV-16 seropositivity was associated with a significantly increased risk of oropharyngeal cancer (adjusted odds ratio, 59.53; 95% confidence interval, 5.71-620.20). Whereas HPV-16 seropositivity was more common in never-smokers with SCCHN than in ever-smokers (43.3% versus 38.3%, respectively), this difference was not statistically significant. Conclusions: HPV-16 infection is associated with a significant increased risk for oropharyngeal cancer but not oral cavity cancer. Furthermore, HPV-16 infection does not appear to be more common in never-smokers than ever-smokers with SCCHN.
引用
收藏
页码:2620 / 2626
页数:7
相关论文
共 50 条
  • [1] Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck
    Pytynia, KB
    Grant, JR
    Etzel, CJ
    Roberts, DB
    Wei, QY
    Sturgis, EM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) : 3981 - 3988
  • [2] Human papillomavirus type 16 and squamous cell carcinoma of the head and neck
    Ringström, E
    Peters, E
    Hasegawa, M
    Posner, M
    Liu, M
    Kelsey, KT
    CLINICAL CANCER RESEARCH, 2002, 8 (10) : 3187 - 3192
  • [3] Human papillomavirus 16 and head and neck squamous cell carcinoma
    Furniss, C. Sloane
    McClean, Michael D.
    Smith, Judith F.
    Bryan, Janine
    Nelson, Heather H.
    Peters, Edwards S.
    Posner, Marshall R.
    Clark, John R.
    Eisen, Ellen A.
    Kelsey, Karl T.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (11) : 2386 - 2392
  • [4] Head and Neck Cancer Among Lifelong Never-Smokers and Ever-Smokers Matched-Pair Analysis of Outcomes After Radiation Therapy
    Chen, Allen M.
    Chen, Leon M.
    Vaughan, Andrew
    Farwell, Donald Gregory
    Luu, Quang
    Purdy, James A.
    Vijayakumar, Srinivasan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (03): : 270 - 275
  • [5] Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
    Abhijeet Beniwal
    Isha Karwasra
    Ashok Parmar
    Hemant Kumar Beniwal
    Jitendra Kumar Sakhrani
    Indian Journal of Surgery, 2018, 80 : 322 - 326
  • [6] HUMAN PAPILLOMAVIRUS AND SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
    Cobzeanu, Mihail Dan
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (01): : 7 - 9
  • [7] Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
    Beniwal, Abhijeet
    Karwasra, Isha
    Parmar, Ashok
    Beniwal, Hemant Kumar
    Sakhrani, Jitendra Kumar
    INDIAN JOURNAL OF SURGERY, 2018, 80 (04) : 322 - 326
  • [8] Human papillomavirus infection and papillary squamous cell carcinoma in the head and neck region
    Yang, Chao-Hui
    Huang, Chao-Cheng
    Ko, Ming-Tse
    Wei, Yu-Ching
    Hwang, Chung-Feng
    TUMOR BIOLOGY, 2013, 34 (01) : 301 - 307
  • [9] Analysis of Fifty Hotspot Mutations of Lung Squamous Cell Carcinoma in Never-smokers
    Lee, Ha Youn
    Lee, Se-Hoon
    Won, Jae-Kyung
    Lee, Dong Soo
    Kwon, Nak-Jung
    Choi, Sun Mi
    Lee, Jinwoo
    Lee, Chang-Hoon
    Lee, Sang-Min
    Yim, Jae-Joon
    Yoo, Chul-Gyu
    Kim, Young Whan
    Han, Sung Koo
    Park, Young Sik
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (03) : 415 - 420
  • [10] NEVER-SMOKERS, NEVER-DRINKERS: UNIQUE CLINICAL SUBGROUP OF YOUNG PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CANCERS
    Harris, Stephen L.
    Kimple, Randall J.
    Hayes, D. Neil
    Couch, Marion E.
    Rosenman, Julian G.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (04): : 499 - 503